These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Spectrophotometric investigation on complex formation of captopril with palladium(II) and its analytical application. Jovanović T, Stanović B, Korićanac Z. J Pharm Biomed Anal; 1995 Mar; 13(3):213-7. PubMed ID: 7619881 [Abstract] [Full Text] [Related]
6. Spectrophotometric determination of captopril with DTNB reagent in pharmaceutical formulation. Hosseinimehr SJ, Ebrahimi P, Hassani N, Mirzabeigi P, Amini M. Boll Chim Farm; 2004 Mar; 143(6):249-51. PubMed ID: 15881803 [Abstract] [Full Text] [Related]
7. Development of a new procedure for the determination of captopril in pharmaceutical formulations employing chemiluminescence and a multicommuted flow analysis approach. Lima MJ, Fernandes RN, Tanaka AA, Reis BF. Luminescence; 2016 Feb; 31(1):288-94. PubMed ID: 26136382 [Abstract] [Full Text] [Related]
8. Exploiting kinetic spectrophotometric determination of captopril, an angiotensin-converting enzyme inhibitor, in a multi-pumping flow system. Prior JA, Santos JL, Lima JL. Anal Chim Acta; 2007 Sep 26; 600(1-2):183-7. PubMed ID: 17903482 [Abstract] [Full Text] [Related]
9. A sensitive kinetic spectrophotometric method for the determination of captopril in bulk and dosage forms. Rahman N, Anwar N, Kashif M, Hoda N. Acta Pharm; 2006 Sep 26; 56(3):347-57. PubMed ID: 19831283 [Abstract] [Full Text] [Related]
16. Validation of simultaneous volumetric and spectrophotometric methods for the determination of captopril in pharmaceutical formulations. Rahman N, Singh M, Hoda N. Farmaco; 2005 Sep 26; 60(6-7):569-74. PubMed ID: 15927181 [Abstract] [Full Text] [Related]